Yanming Ren

Dr. Yanming Ren


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
LYliu yan
liu yan
LLLi LU
Li LU
WWWen-Xin Wang
Wen-Xin Wang
SLShou Liu
Shou Liu
HCHong-Ru Chen
Hong-Ru Chen
CWChao-Cai Wang
Chao-Cai Wang
Background: This study aimed to examine the degrees of job burnout and occupational stressors and their associations among healthcare professionals from county-level health alliances in Qinghai–Tibet Plateau, China. Methods: A cross-sectional study was conducted in county-level health alliances in Qinghai Province, China, in November 2018. The Maslach Burnout Inventory—General Survey and the 38-item Chinese version of the “Scale for occupational stressors on clinicians” were used. Medical staff in four health alliances from two counties were invited to complete the questionnaire. Results: A total of 1052 (age: 34.06 ± 9.22 years, 79.1% females) healthcare professionals were included, 68.2% (95% CI: 65.2–71.0%) of the participants had job burnout symptoms. Occupational stressors had positive associations with moderate (OR = 1.06, 95% CI: 1.05–1.07) and serious (OR = 1.15, 95% CI: 1.13–1.19) level of job burnout. Stressors from vocational interest produced the greatest magnitude of odds ratio (OR = 1.76, 95% CI: 1.62–1.92) for serious degree of burnout, followed by doctor–patient relationship, interpersonal relationship as well as other domains of occupational stressors. Conclusions: Job burnout was very common among healthcare professionals working in Chinese county-level health alliances, different occupational stressors had associations with job burnout. Appropriate and effective policies and measures should be developed and implemented.

10 January 2023 in Frontiers in Public Health
Verified
Journal Article
Open access
WPWen Peng
Wen Peng
WJWenxiu Jian
Wenxiu Jian
TLTiemei Li
Tiemei Li
MMMaureen Malowany
Maureen Malowany
XTXiao Tang
Xiao Tang
YRYanming Ren
Yanming Ren
Background: Non-communicable diseases (NCDs) including risk factors, e.g., obesity, are the major causes of preventable deaths in China, yet NCD disparities in China remain under-studied.Objective: This study aimed to compare the determinants and burden of NCDs within four selected provinces in mainland China: the least developed Qinghai-Tibet Plateau group (PG, Tibetan Autonomous Region [TAR] and Qinghai Province) and most developed megacity group (MCG, Shanghai, and Beijing).Methods: Studies, reports, and other official sources with comparable data for NCD burden and related determinants for the four provinces were searched. Geographic, demographic, socioeconomic, and dietary characteristics and selected health indicators (e.g., life expectancy) were extracted from the China Statistical Yearbook and China Health Statistics Yearbook. Data on NCD burdens were extracted from the National Chronic Disease and Risk Factor Surveillance Study and other nationally representative studies.Results: The overall NCD mortality rates and prevalence of metabolic risk factors including obesity, hypertension, and diabetes in mainland China have increased in the past 20 years, and this trend is expected to continue. The PG had the highest level of standardized mortality rates (SMRs) on NCDs (711.6–896.1/100,000, 6th/6-level); the MCG had the lowest (290.6–389.6/100,000, 1st/6-level) in mainland China. The gaps in SMRs were particularly high with regard to chronic respiratory diseases (PG 6th/6-level, MCG 1st/6-level) and cardiovascular diseases (6th/6 and 4th/6 in TAR and Qinghai; 1st/6-level and 2nd/6-level in Shanghai and Beijing). In contrast, the prevalence rates of obesity, hypertension, and diabetes were generally higher or comparable in MCG compared to PG. Diabetes prevalence was particularly high in MCG (5th/5-level, 13.36–14.35%) and low in PG (1st/5-level, 6.20–10.39%). However, awareness, treatment, and control of hypertension were poor in PG. Additionally, PG had much lower and severely inadequate intakes of vegetables, fruits, and dairy products, with additional indicators of lower socioeconomic status (education, income, etc.,) compared with MCG.Conclusion: Evidence showed large disparities in NCD burden in China's provinces. Socioeconomic disparity and dietary determinants are probably the reasons. Integrated policies and actions are needed.

21 August 2025 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
LZLong Zhu
Long Zhu
YMYaolei Ma
Yaolei Ma
AKAo Kong
Ao Kong
XWXiangjun Wu
Xiangjun Wu
YRYanming Ren
Yanming Ren
YGYue Gao
Yue Gao
Radiotherapy inevitably cause cognitive dysfunction. We aim to explore a non-invasive, sensitive strategy for assessing radiation-induced cognitive dysfunction, using voxel-based morphometry (VBM) and functional connectivity (FC), and to clarify the potential mechanisms from behavioral, histological, and molecular perspectives. We employed a multimodal cross-validation strategy to evaluate cognitive dysfunction of C57BL/6j mice exposed to a single dose of 5 Gy or 15 Gy using a 60Co γ radiation source. The open field, novel object recognition, and Morris water maze tests were conducted on days 18, 19, and 21 after radiation, respectively, followed by fMRI scanning on day 27. VBM and FC analysis are used to assess cognitive function impairment after radiation. Histopathological analyses (HE and Nissl staining) and immunohistochemical assessments of neural damage markers (Iba-1 and GFAP) were conducted. The radiation group (5 Gy, 15 Gy) showed an increased escape latency, decreased number of platform crossings, and no difference in exploration preference for old versus new objects. In the radiation group, the arrangement of neurons in the hippocampal DG region was disordered, and a significant reduction of Nissl bodies was observed. The expression of Iba1 (in CA1, CA2, and CA3 regions) and GFAP (in CA1 and CA3 regions) was increased after radiation. The levels of pro-inflammatory factors such as IFN-gamma and IL-1beta were increased in the hippocampal tissue, while the expression of anti-inflammatory factors (IL-4 and IL-10) were decreased. The brain region with increased gray matter volume in the 5 Gy group was the right hippocampal DG region. Functional connectivity values were increased between 24 pairs of hippocampal subregions, such as CA1.R and DG-mo.L, while decreased between 29 pairs, such as CA3.R and ENTl1.R in the 5 Gy group. In the 15 Gy group, functional connectivity values increased between 31 pairs, such as DG-mo.L and HATA.R, and decreased between 20 pairs, such as CA2.R and DG-po.L. Compared to the 5 Gy group, the 15 Gy group had 33 pairs with increased functional connectivity values and 23 pairs with decreased values. Functional magnetic resonance imaging can non-invasively and more efficiently assess cognitive function impairment in the brain after radiation doses using VBM and FC comparative methods. This provides new insights into the evaluation of cognitive function with non-invasive and sensitive methods.

28 April 2025 in Public Health Nutrition
Verified
Journal Article
Open access
PDF file
WJWenxiu Jian
Wenxiu Jian
BZBin Zhang
Bin Zhang
YMYue Ma
Yue Ma
XTXiao Tang
Xiao Tang
TNTuan Thanh Nguyen
Tuan Thanh Nguyen
WPWen Peng
Wen Peng
Objective: We aimed to validate in-body bioelectrical impedance analysis (BIA) measures with dual-energy X-ray absorptiometry (DXA) as reference and describe the body composition (BC) profiling of Tibetan adults. Design: This cross-sectional study included 855 participants (391 men and 464 women). Correlation and Bland–Altman analyses were performed for method agreement of in-body BIA and DXA. BC were described by obesity and metabolic status. Setting: In-body BIA and DXA have not been employed to characterise the BC of the Tibetan population living in the Qinghai–Tibet Plateau. Participants: A total of 855 Tibetan adults, including 391 men and 464 women, were enrolled in the study. Results: Concordance correlation coefficient for total fat mass (FM) and total lean mass (LM) between in-body BIA and DXA were 0·91 and 0·89. The bias of in-body BIA for percentages of total FM and total LM was 0·91 % (2·46 %) and –1·74 % (–2·80 %) compared with DXA, respectively. Absolute limits of agreement were wider for total FM in obese men and women and for total LM in overweight men than their counterparts. Gradience in the distribution of total and regional FM content was observed across different BMI categories and its combinations with waist circumference and metabolic status. Conclusions: In-body BIA and DXA provided overall good agreement at the group level in Tibetan adults, but the agreement was inferior in participants being overweight or obese.

31 May 2025 in Intractable & Rare Diseases Research
Verified
Journal Article
Open access
PDF file
YLYuanzheng Liu
Yuanzheng Liu
YRYanming Ren
Yanming Ren
PSPeipei Song
Peipei Song
Rare diseases have become a global public health challenge due to their low prevalence, difficult diagnosis, and limited treatment options. Intractable diseases are more common but often involve complex mechanisms, treatment with limited efficacy, and high medical costs, placing a heavy burden on patients and healthcare systems. In recent years, traditional Chinese medicine (TCM) has demonstrated unique advantages in the treatment of intractable and rare diseases and has gradually become an important complementary treatment. The current work is a systematic review of the progress of clinical and experimental research on TCM in typical rare diseases such as amyotrophic lateral sclerosis (ALS), systemic lupus erythematosus (SLE), mitochondrial encephalomyopathy, aplastic anemia (AA), and Wilson's disease (WD). It focuses on the multi-target therapeutic mechanisms of key Chinese herbal compound formulas, including immune regulation, antioxidative stress, and neuroprotection. The core TCM theories of "syndrome differentiation", "different treatments for the same disease" and the "same treatment for different diseases" are also discussed in the context of personalized medicine. In recent years, China has continuously promoted the development of TCM through a series of national plans and supportive policies, such as the 14th Five-Year Plan for TCM development, funding for key special projects, expedited approval pathways, and expanded coverage by medical insurance. These efforts have provided strong support for the clinical translation of TCM and technological innovation in the field of intractable and rare diseases. Notwithstanding the encouraging advances, the field of Chinese medicine continues to grapple with numerous challenges. In the future, the enhancement of mechanistic studies and quality multicenter clinical trials needs to be promoted while further enhancing policy support and international collaboration to substantiate the scientific basis and clinical value of TCM in the prevention and treatment of intractable and rare diseases.

30 June 2025 in Drug Discoveries & Therapeutics
Verified
Journal Article
Open access
PDF file
YLYuanzheng Liu
Yuanzheng Liu
SKSusumu Kobayashi
Susumu Kobayashi
LWLing Wang
Ling Wang
YRYanming Ren
Yanming Ren
PSPeipei Song
Peipei Song
Menopausal symptoms primarily result from ovarian dysfunction and declining estrogen levels, leading to multisystem disorders. Although hormone therapy remains the most effective treatment, its long-term use is associated with significant risks, prompting interest in alternative options. Kampo medicine, a traditional Japanese system derived from Chinese herbal medicine, has gained renewed attention as a complementary and personalized therapeutic approach to menopausal health. This review aims to systematically summarize the current application and clinical evidence of Kampo medicine in the management of menopausal symptoms across multiple domains, including vasomotor, neuropsychiatric, musculoskeletal, skeletal, and genitourinary systems. Furthermore, the review seeks to further validate its efficacy through the mechanistic actions of its key ingredients. While the therapeutic effects of Kampo medicine on hot flashes have been inconsistent, it has demonstrated significant efficacy in improving emotional disturbances, sleep disorders, and somatic symptoms, particularly among individuals whose conditions are not driven solely by hormonal imbalances. In the management of osteoporosis, the integration of Kampo medicine with conventional Western treatments not only enhances overall therapeutic outcomes but also contributes to the reduction of adverse effects. One limitation of current research is the lack of randomized controlled trials (RCTs) evaluating the efficacy of Kampo medicine in managing Genitourinary Syndrome of Menopause (GSM), highlighting the need for further investigation in this area. The integration of Kampo medicine into menopausal symptom management may contribute to a more holistic, patient-centered approach that offers both traditional and Western medical options. This integrative model has the potential to support shared decision-making and improve personalized care for menopausal women.